CLEAN SLATE (880906)

  https://cordis.europa.eu/project/id/880906

  Horizon 2020 (2014-2020)

  LightSense's Breakthrough medical device for aesthetic healthcare

  SME instrument (EIC-SMEInst-2018-2020)

  entrepreneurship  ·  dermatology  ·  laser physics

  2019-06-15 Start Date (YY-MM-DD)

  2021-06-14 End Date (YY-MM-DD)

  € 3,017,625 Total Cost


  Description

Founded by a world-leading physicist and a track-record technology entrepreneur, LightSense has developed and patented a breakthrough technology that dramatically improves non-invasive dermatological healthcare. We plan to bring this technology to market through skincare clinics. We will initially offer aesthetic dermatology services focused on exogenous and endogenous pigments because (1) there is large and growing market, over 100 million people - and growing - are looking for a solution; (2) current treatment offerings are ineffective, painful, damaging to skin tissue, and very lengthy; (3) our technology breakthrough positions us to offer a significantly better treatment experience; (4) we already have significant intellectual property protection that enables successful go to market. With success in treating pigmentation disorders, we intend to quickly expand our offer, establishing industry-wide and academically-recognised solutions for many laser dermatology procedures. This project focuses on finalising product development and testing, and gaining regulatory approval through clinical studies, and final commercialisation of the innovation.


  Complicit Organisations

1 Israeli organisation participates in CLEAN SLATE.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
United Kingdom LIGHTSENSE TECHNOLOGIES LTD (910414453) GB268995426 coordinator PRC € 3,017,625 € 2,112,337 € 944,596
Israel LIGHTSENSE ISRAEL LTD (888495169) IL515731156 thirdParty PRC € 1,668,200 € 0 € 1,167,740